April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Evaluation of Haptoglobin and Its Isoforms as Plasma/Serum Biomarker for Diabetic Retinopathy
Author Affiliations & Notes
  • M. Valar Nila
    Dr.G.Venkataswamy Eye Research Institute, AMRF, Aravind Eye Hospital, Madurai, India
  • T. P. Vignesh
    Retina Clinic, Aravind Eye Hospital, Madurai, India
  • V. R. Muthukkaruppan
    Dr.G.Venkataswamy Eye Research Institute, AMRF, Aravind Eye Hospital, Madurai, India
  • K. Dharmalingam
    Madurai Kamaraj University, Madurai, India
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5088. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Valar Nila, T. P. Vignesh, V. R. Muthukkaruppan, K. Dharmalingam; Evaluation of Haptoglobin and Its Isoforms as Plasma/Serum Biomarker for Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5088.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : This study aims at the identification of post translational modifications of proteins in Diabetic Retinopathy (DR) patients and the validation of these putative biomarkers for early diagnosis and progression of Non-Proliferative Diabetic Retinopathy (NPDR) to severe Proliferative Diabetic Retinopathy (PDR).

Methods: : Thirty serum samples from PDR, NPDR, NDR (Diabetes without Retinopathy), and Normal age matched controls were examined, using Two Dimensional Polyacrylamide Gel Electrophoresis (2D PAGE) to view the complete protein profile and to analyze the Haptoglobin expression and isoform changes, followed by MALDI TOF and Nano LC MS/MS based identification and quantification of differentially expressed proteins.

Results: : The protein profiling of the PDR sera differed from that of NDR, NPDR and controls. There is differential regulation of Haptoglobin isoforms in PDR patients. Interestingly, in Haptoglobin α2 chain - isofrom α2M is significantly upregulated in PDR. Further, among the 56 identified proteins, Ceruloplasmin, Alpha-1B-glycoprotein precursor, Serotransferrin precursor, Ig mu chain C region, Isocitrate dehydrogenase, Apolipoprotein A-IV precursor, Haptoglobin precursor were upregulated and Haemoglobin alpha chain, Haemoglobin beta chain, Albumin Isoform were downregulated in PDR serum.

Conclusions: : Serum proteomic approaches prove to be useful in the investigation of disease pathogenesis. Most of the upregulated proteins are associated with the disease progression, thereby giving fundamental information for further research. In humans the genetic polymorphism of Haptoglobin 2-2 phenotype was shown to be associated with the prevalence and microvascular complications, in both the types of Diabetes Mellitus (DM). Based on our results, we propose that the analysis of Haptoglobin expression and isoform changes and also analysis of post translational modification of other serum proteins, will allow us to uncover a biomarker for early diagnosis and disease progression.

Keywords: diabetic retinopathy • proteomics • protein modifications-post translational 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×